Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules - PubMed (original) (raw)
Comparative Study
Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules
H Golding et al. J Virol. 1995 Oct.
Abstract
The entry of human immunodeficiency virus type 1 into cells proceeds via a fusion mechanism that is initiated by binding of the viral glycoprotein gp120-gp41 to its cellular receptor CD4. Species- and tissue-specific restrictions to viral entry suggested the participation of additional membrane components in the postbinding fusion events. In a previous study (H. Golding, J. Manischewitz, L. Vujcic, R. Blumenthal, and D. Dimitrov, J. Virol. 68:1962-1968, 1994), it was found that phorbol myristate acetate (PMA) inhibits human immunodeficiency virus type 1 envelope-mediated cell fusion by inducing down modulation of an accessory component(s) in the CD4-expressing cells. The fusion inhibition was seen in a variety of cells, including T-cell transfectants expressing engineered CD4 receptors (CD4.401 and CD4.CD8) which are not susceptible to down modulation by PMA treatment. In the current study, it was found that preincubation of A2.01.CD4.401 cells with soluble monomeric gp120 for 1 h at 37 degrees C primed them for PMA-induced down modulation (up to 70%) of the tailless CD4 receptors. The gp120-priming effect was temperature dependent, and the down modulation may have occurred via clathrin-coated pits. Importantly, nonhuman cell lines expressing tailless CD4 molecules did not down modulate their CD4 receptors under the same conditions. The gp120-dependent PMA-induced down modulation of tailless CD4 receptors could be efficiently blocked by the human monoclonal antibodies 48D and 17B, which bind with increased avidity to gp120 that was previously bound to CD4 (M. Thali, J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski, J. Virol. 67:3978-3988, 1993). These findings suggest that gp120 binding to cellular CD4 receptors induces conformational changes leading to association of the gp120-CD4 complexes with accessory transmembrane molecules that are susceptible to PMA-induced down modulation and can target the virions to clathrin-coated pits.
Similar articles
- The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
Golding H, Manischewitz J, Vujcic L, Blumenthal R, Dimitrov DS. Golding H, et al. J Virol. 1994 Mar;68(3):1962-9. doi: 10.1128/JVI.68.3.1962-1969.1994. J Virol. 1994. PMID: 7906314 Free PMC article. - Differential level in co-down-modulation of CD4 and CXCR4 primed by HIV-1 gp120 in response to phorbol ester, PMA, among HIV-1 isolates.
Tahara-Hanaoka S, Ushijima Y, Tarui H, Wada M, Hara T, Imanishi S, Yamaguchi T, Hattori T, Nakauchi H, Koito A. Tahara-Hanaoka S, et al. Microbiol Immunol. 2000;44(6):489-98. doi: 10.1111/j.1348-0421.2000.tb02524.x. Microbiol Immunol. 2000. PMID: 10941932 - Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.
Lee S, Peden K, Dimitrov DS, Broder CC, Manischewitz J, Denisova G, Gershoni JM, Golding H. Lee S, et al. J Virol. 1997 Aug;71(8):6037-43. doi: 10.1128/JVI.71.8.6037-6043.1997. J Virol. 1997. PMID: 9223495 Free PMC article. - CD4 activation of HIV fusion.
Sattentau QJ. Sattentau QJ. Int J Cell Cloning. 1992 Nov;10(6):323-32. doi: 10.1002/stem.5530100603. Int J Cell Cloning. 1992. PMID: 1281202 Review. - The role of CD4 in HIV binding and entry.
Sattentau QJ, Moore JP. Sattentau QJ, et al. Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):59-66. doi: 10.1098/rstb.1993.0136. Philos Trans R Soc Lond B Biol Sci. 1993. PMID: 7904348 Review.
Cited by
- Receptor binding domain based HIV vaccines.
Liu H, Bi W, Wang Q, Lu L, Jiang S. Liu H, et al. Biomed Res Int. 2015;2015:594109. doi: 10.1155/2015/594109. Epub 2015 Jan 15. Biomed Res Int. 2015. PMID: 25667925 Free PMC article. Review. - Protein kinase C and NF-κB-dependent CD4 downregulation in macrophages induced by T cell-derived soluble factors: consequences for HIV-1 infection.
Raposo RA, Trudgian DC, Thomas B, van Wilgenburg B, Cowley SA, James W. Raposo RA, et al. J Immunol. 2011 Jul 15;187(2):748-59. doi: 10.4049/jimmunol.1003678. Epub 2011 Jun 10. J Immunol. 2011. PMID: 21666058 Free PMC article. - Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
Yang QE, Stephen AG, Adelsberger JW, Roberts PE, Zhu W, Currens MJ, Feng Y, Crise BJ, Gorelick RJ, Rein AR, Fisher RJ, Shoemaker RH, Sei S. Yang QE, et al. J Virol. 2005 May;79(10):6122-33. doi: 10.1128/JVI.79.10.6122-6133.2005. J Virol. 2005. PMID: 15857997 Free PMC article. - Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S, Lapham CK, Chen H, King L, Manischewitz J, Romantseva T, Mostowski H, Stantchev TS, Broder CC, Golding H. Lee S, et al. J Virol. 2000 Jun;74(11):5016-23. doi: 10.1128/jvi.74.11.5016-5023.2000. J Virol. 2000. PMID: 10799575 Free PMC article. - N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.
Chabot DJ, Chen H, Dimitrov DS, Broder CC. Chabot DJ, et al. J Virol. 2000 May;74(9):4404-13. doi: 10.1128/jvi.74.9.4404-4413.2000. J Virol. 2000. PMID: 10756055 Free PMC article.
References
- J Exp Med. 1990 Oct 1;172(4):1143-50 - PubMed
- J Virol. 1995 Feb;69(2):1013-8 - PubMed
- J Virol. 1991 Jan;65(1):31-41 - PubMed
- J Exp Med. 1991 Mar 1;173(3):575-87 - PubMed
- J Biol Chem. 1991 Jun 5;266(16):10658-65 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials